Clinical Trial Update: S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer

View source ↗

Summary

SWOG trial S9719 studied gene damage after chemotherapy in women with stage II or III breast cancer. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer | Status: COMPLETED